Patients' awareness of recovery mediates the link between clinical and level of functional remission in schizophrenia to a larger extent in those treated with long-acting antipsychotics.

BACKGROUND

Clinical remission is a step towards functional remission for subjects with schizophrenia. While recovery is both a subjective personal journey and a clinical outcome to be targeted, data on patient self-rated outcomes are scarce.

OBJECTIVES

(i) To determine the extent to which the association between clinical and functional remission is mediated by the subjective experience of recovery as reported by patients their relatives or their psychiatrist and (ii) to assess differences according to treatment, specifically with oral antipsychotics only long-acting injectable antipsychotics (LAIs).

DESIGN

Clinical observational study.

METHODS

Community-dwelling participants with schizophrenia enrolled in the EGOFORS cohort ( = 198) were included. Clinical symptoms and remission were assessed using the Positive and Negative Syndrome Scale. Functional remission was assessed with the Functional Remission of General Schizophrenia Scale. Awareness of recovery was assessed with one question 'What percentage of recovery do you think you have now (from 0% - no recovery - to 100% - full recovery)?', asked of the patient, also of the patient's close relative, and the psychiatrist. We used mediation analyses, taking into account the type of pharmacological treatment.

RESULTS

Remission criteria and perceived remission measures were significantly correlated, both within and between groups ( > 0.330). The patient's awareness of recovery mediated the relationship between clinical remission and level of functional remission, while the level of recovery according to psychiatrists or close relatives did not. The direct effect of clinical remission on the level of functional remission became non-significant when taking into account the mediator (patients' awareness of recovery) in the group of patients with LAI ( = 1.5,  = 0.150) but not in the group of patients with other treatments ( = 3.1,  = 0.003).

CONCLUSION

Patients with LAIs may be more efficient in reporting their level of functional remission. Higher patient awareness could be an interesting candidate to explain this. However, as the study was cross-sectional, such a proposal should be tested with a more specifically designed protocol, such as a long-term cohort.